NCV’s data shows flat-to-declining revenue momentum for many public operators while the market fixates on 280E and rescheduling risk—here’s what that means for DMV investors and delivery entrepreneurs.

An Australian firm filed a THC-free CBD pain tablet with TGA approval in mind, but its own trial reportedly didn’t beat placebo—raising product, market, and investor questions.

Georgia regulators greenlight home delivery for registered patients and permit university research with state-program products—changes that could reshape access and evidence-building.

A Texas case profiled by High Times shows how extreme cannabis penalties still happen. Here’s what DMV readers should consider about risk, compliance and delivery rules.

New York’s legal cannabis market is tracking toward a new annual high while early indicators point to a cooling trend. Here’s what that mix of growth and hesitation could mean for delivery, compliance, and DMV operators watching from the sidelines.

New York just doubled its licensed dispensaries to 556, with 200+ in NYC. Here’s what that expansion signals for delivery models, investors, and DMV entrepreneurs.

Discounts near 26%, classic strain names like Blue Dream still moving units, and compliance pressures shape delivery models and investment risk in late 2026.

Michigan’s cannabis regulator yanked 20 medical cultivation licenses from GP Holdings (Millie Montana Industries) and levied a $2M fine. Here’s what happened—and what delivery operators, investors, and DMV entrepreneurs should learn from it.

Los Angeles’ leading mayoral candidate unveiled a plan to fix the city’s “broken” cannabis market. Here’s what it could mean for delivery models, investors, and DMV entrepreneurs.

The Nasdaq notice lifts delisting risk for IM Cannabis and spotlights how bid-price compliance can ripple across marijuana delivery stocks, founders, and DMV investors.

Holiday demand surges are real—but uneven. Here’s a compliant, delivery-forward plan DC, Maryland, and Virginia operators can use to staff smart, stock right, and serve safely.

A $2,500 settlement over about 200 plants shows how fast compliance gaps become costly. Here’s what DMV operators, delivery builders, and investors should learn now.

Connecticut’s volume is up but dollars aren’t keeping pace. Here’s what price compression means for cannabis delivery models, investors, and DMV operators planning their next move.

A cannabis-only group captive for employer health plans aims to cut overhead, increase cost control, and protect margins for delivery operators and dispensaries in the DMV and beyond.

A federal ban on intoxicating hemp products could shutter most U.S. hemp businesses. Here’s how the disruption ripples through delivery models, apps, and DMV operators—and what to do next.

A new federal court ruling, recalls, and retail trends are shifting risk and opportunity for cannabis delivery apps, couriers, and investors across the DMV.

AI is lowering the barrier for cybercrime, and cannabis delivery and retail are in the crosshairs. Here’s what DMV operators, investors, and app builders should do now.

Vegas’ CHAMPS show ran tighter and busier, spotlighting hemp beverage bets and delivery-ready retail tactics—signals DMV operators and investors should read now.

Operational change is the earliest safety-and-cost signal in cannabis logistics. Here’s how delivery operators and investors can turn risk awareness into business edge.

MJBizDaily reports Endovia is seeking FDA veterinary approval for a cannabinoid drug aimed at canine cancer and chronic pain—an R&D path that could reshape investor focus.